LymphedemaV1, PubMed, Curation, bibRecord, 001283

Patterns of recurrence and role of pelvic radiotherapy in ovarian clear cell adenocarcinoma.

Identifieur interne : 001283 ( PubMed/Curation ); précédent : 001282; suivant : 001284

Patterns of recurrence and role of pelvic radiotherapy in ovarian clear cell adenocarcinoma.

Auteurs : Bryan D. Macrie ; Jonathan B. Strauss ; Irene B. Helenowski ; Alfred Rademaker ; Julian C. Schink ; John R. Lurain ; William Small

Source :

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society [ 1525-1438 ] ; 2014.

RBID : pubmed:25275661

Descripteurs français

English descriptors

KwdEn :
- Adenocarcinoma, Clear Cell (complications), Adenocarcinoma, Clear Cell (pathology), Adenocarcinoma, Clear Cell (therapy), Adult, Aged, Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Chicago (epidemiology), Combined Modality Therapy, Endometrial Neoplasms (complications), Endometrial Neoplasms (pathology), Endometrial Neoplasms (therapy), Female, Follow-Up Studies, Humans, Incidence, Middle Aged, Neoplasm Grading, Neoplasm Recurrence, Local (epidemiology), Neoplasm Recurrence, Local (prevention & control), Neoplasm Staging, Neoplasms, Glandular and Epithelial (complications), Neoplasms, Glandular and Epithelial (pathology), Neoplasms, Glandular and Epithelial (therapy), Ovarian Neoplasms (complications), Ovarian Neoplasms (pathology), Ovarian Neoplasms (therapy), Pelvic Neoplasms (etiology), Pelvic Neoplasms (pathology), Pelvic Neoplasms (radiotherapy), Prognosis, Retrospective Studies.
MESH :
- geographic , epidemiology : Chicago.
- complications : Adenocarcinoma, Clear Cell, Endometrial Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms.
- epidemiology : Neoplasm Recurrence, Local.
- etiology : Pelvic Neoplasms.
- pathology : Adenocarcinoma, Clear Cell, Endometrial Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Pelvic Neoplasms.
- prevention & control : Neoplasm Recurrence, Local.
- radiotherapy : Pelvic Neoplasms.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- therapy : Adenocarcinoma, Clear Cell, Endometrial Neoplasms, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms.
- Adult, Aged, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Incidence, Middle Aged, Neoplasm Grading, Neoplasm Staging, Prognosis, Retrospective Studies.

Abstract

The aims of this study were to analyze patterns of recurrence in patients with ovarian clear cell adenocarcinoma (CCA) and to evaluate the role of pelvic radiotherapy (RT).

DOI: 10.1097/IGC.0000000000000270
PubMed: 25275661

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001283

Links to Exploration step

pubmed:25275661

Curation

No country items

Bryan D. Macrie

<affiliation><nlm:affiliation>*Department of Radiation Oncology and †Department of Preventive Medicine, Division of Biostatistics, Northwestern University Feinberg School of Medicine; ‡Robert H. Lurie Comprehensive Cancer Center and §Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Northwestern University Feinberg School of Medicine; ∥Department of Radiation Oncology, Stritch School of Medicine, Loyola University Chicago.</nlm:affiliation>
<wicri:noCountry code="subField">Loyola University Chicago</wicri:noCountry>
</affiliation>

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Patterns of recurrence and role of pelvic radiotherapy in ovarian clear cell adenocarcinoma.</title>
<author><name sortKey="Macrie, Bryan D" sort="Macrie, Bryan D" uniqKey="Macrie B" first="Bryan D" last="Macrie">Bryan D. Macrie</name>
<affiliation><nlm:affiliation>*Department of Radiation Oncology and †Department of Preventive Medicine, Division of Biostatistics, Northwestern University Feinberg School of Medicine; ‡Robert H. Lurie Comprehensive Cancer Center and §Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Northwestern University Feinberg School of Medicine; ∥Department of Radiation Oncology, Stritch School of Medicine, Loyola University Chicago.</nlm:affiliation>
<wicri:noCountry code="subField">Loyola University Chicago</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Strauss, Jonathan B" sort="Strauss, Jonathan B" uniqKey="Strauss J" first="Jonathan B" last="Strauss">Jonathan B. Strauss</name>
</author>
<author><name sortKey="Helenowski, Irene B" sort="Helenowski, Irene B" uniqKey="Helenowski I" first="Irene B" last="Helenowski">Irene B. Helenowski</name>
</author>
<author><name sortKey="Rademaker, Alfred" sort="Rademaker, Alfred" uniqKey="Rademaker A" first="Alfred" last="Rademaker">Alfred Rademaker</name>
</author>
<author><name sortKey="Schink, Julian C" sort="Schink, Julian C" uniqKey="Schink J" first="Julian C" last="Schink">Julian C. Schink</name>
</author>
<author><name sortKey="Lurain, John R" sort="Lurain, John R" uniqKey="Lurain J" first="John R" last="Lurain">John R. Lurain</name>
</author>
<author><name sortKey="Small, William" sort="Small, William" uniqKey="Small W" first="William" last="Small">William Small</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:25275661</idno>
<idno type="pmid">25275661</idno>
<idno type="doi">10.1097/IGC.0000000000000270</idno>
<idno type="wicri:Area/PubMed/Corpus">001283</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001283</idno>
<idno type="wicri:Area/PubMed/Curation">001283</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001283</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Patterns of recurrence and role of pelvic radiotherapy in ovarian clear cell adenocarcinoma.</title>
<author><name sortKey="Macrie, Bryan D" sort="Macrie, Bryan D" uniqKey="Macrie B" first="Bryan D" last="Macrie">Bryan D. Macrie</name>
<affiliation><nlm:affiliation>*Department of Radiation Oncology and †Department of Preventive Medicine, Division of Biostatistics, Northwestern University Feinberg School of Medicine; ‡Robert H. Lurie Comprehensive Cancer Center and §Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Northwestern University Feinberg School of Medicine; ∥Department of Radiation Oncology, Stritch School of Medicine, Loyola University Chicago.</nlm:affiliation>
<wicri:noCountry code="subField">Loyola University Chicago</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Strauss, Jonathan B" sort="Strauss, Jonathan B" uniqKey="Strauss J" first="Jonathan B" last="Strauss">Jonathan B. Strauss</name>
</author>
<author><name sortKey="Helenowski, Irene B" sort="Helenowski, Irene B" uniqKey="Helenowski I" first="Irene B" last="Helenowski">Irene B. Helenowski</name>
</author>
<author><name sortKey="Rademaker, Alfred" sort="Rademaker, Alfred" uniqKey="Rademaker A" first="Alfred" last="Rademaker">Alfred Rademaker</name>
</author>
<author><name sortKey="Schink, Julian C" sort="Schink, Julian C" uniqKey="Schink J" first="Julian C" last="Schink">Julian C. Schink</name>
</author>
<author><name sortKey="Lurain, John R" sort="Lurain, John R" uniqKey="Lurain J" first="John R" last="Lurain">John R. Lurain</name>
</author>
<author><name sortKey="Small, William" sort="Small, William" uniqKey="Small W" first="William" last="Small">William Small</name>
</author>
</analytic>
<series><title level="j">International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</title>
<idno type="eISSN">1525-1438</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma, Clear Cell (complications)</term>
<term>Adenocarcinoma, Clear Cell (pathology)</term>
<term>Adenocarcinoma, Clear Cell (therapy)</term>
<term>Adult</term>
<term>Aged</term>
<term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term>
<term>Chicago (epidemiology)</term>
<term>Combined Modality Therapy</term>
<term>Endometrial Neoplasms (complications)</term>
<term>Endometrial Neoplasms (pathology)</term>
<term>Endometrial Neoplasms (therapy)</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
<term>Middle Aged</term>
<term>Neoplasm Grading</term>
<term>Neoplasm Recurrence, Local (epidemiology)</term>
<term>Neoplasm Recurrence, Local (prevention & control)</term>
<term>Neoplasm Staging</term>
<term>Neoplasms, Glandular and Epithelial (complications)</term>
<term>Neoplasms, Glandular and Epithelial (pathology)</term>
<term>Neoplasms, Glandular and Epithelial (therapy)</term>
<term>Ovarian Neoplasms (complications)</term>
<term>Ovarian Neoplasms (pathology)</term>
<term>Ovarian Neoplasms (therapy)</term>
<term>Pelvic Neoplasms (etiology)</term>
<term>Pelvic Neoplasms (pathology)</term>
<term>Pelvic Neoplasms (radiotherapy)</term>
<term>Prognosis</term>
<term>Retrospective Studies</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Adénocarcinome à cellules claires ()</term>
<term>Adénocarcinome à cellules claires (anatomopathologie)</term>
<term>Association thérapeutique</term>
<term>Chicago (épidémiologie)</term>
<term>Femelle</term>
<term>Grading des tumeurs</term>
<term>Humains</term>
<term>Incidence</term>
<term>Pronostic</term>
<term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term>
<term>Récidive tumorale locale ()</term>
<term>Récidive tumorale locale (épidémiologie)</term>
<term>Stade de la tumeur</term>
<term>Sujet âgé</term>
<term>Tumeurs de l'endomètre ()</term>
<term>Tumeurs de l'endomètre (anatomopathologie)</term>
<term>Tumeurs de l'ovaire ()</term>
<term>Tumeurs de l'ovaire (anatomopathologie)</term>
<term>Tumeurs du bassin (anatomopathologie)</term>
<term>Tumeurs du bassin (radiothérapie)</term>
<term>Tumeurs du bassin (étiologie)</term>
<term>Tumeurs épithéliales épidermoïdes et glandulaires ()</term>
<term>Tumeurs épithéliales épidermoïdes et glandulaires (anatomopathologie)</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Chicago</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Adénocarcinome à cellules claires</term>
<term>Tumeurs de l'endomètre</term>
<term>Tumeurs de l'ovaire</term>
<term>Tumeurs du bassin</term>
<term>Tumeurs épithéliales épidermoïdes et glandulaires</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Adenocarcinoma, Clear Cell</term>
<term>Endometrial Neoplasms</term>
<term>Neoplasms, Glandular and Epithelial</term>
<term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Neoplasm Recurrence, Local</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Pelvic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma, Clear Cell</term>
<term>Endometrial Neoplasms</term>
<term>Neoplasms, Glandular and Epithelial</term>
<term>Ovarian Neoplasms</term>
<term>Pelvic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Neoplasm Recurrence, Local</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Pelvic Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs du bassin</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Adenocarcinoma, Clear Cell</term>
<term>Endometrial Neoplasms</term>
<term>Neoplasms, Glandular and Epithelial</term>
<term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Chicago</term>
<term>Récidive tumorale locale</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Tumeurs du bassin</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Incidence</term>
<term>Middle Aged</term>
<term>Neoplasm Grading</term>
<term>Neoplasm Staging</term>
<term>Prognosis</term>
<term>Retrospective Studies</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Adénocarcinome à cellules claires</term>
<term>Association thérapeutique</term>
<term>Femelle</term>
<term>Grading des tumeurs</term>
<term>Humains</term>
<term>Incidence</term>
<term>Pronostic</term>
<term>Récidive tumorale locale</term>
<term>Stade de la tumeur</term>
<term>Sujet âgé</term>
<term>Tumeurs de l'endomètre</term>
<term>Tumeurs de l'ovaire</term>
<term>Tumeurs épithéliales épidermoïdes et glandulaires</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The aims of this study were to analyze patterns of recurrence in patients with ovarian clear cell adenocarcinoma (CCA) and to evaluate the role of pelvic radiotherapy (RT).</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25275661</PMID>
<DateCreated><Year>2014</Year>
<Month>10</Month>
<Day>28</Day>
</DateCreated>
<DateCompleted><Year>2015</Year>
<Month>07</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised><Year>2014</Year>
<Month>10</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1525-1438</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>24</Volume>
<Issue>9</Issue>
<PubDate><Year>2014</Year>
<Month>Nov</Month>
</PubDate>
</JournalIssue>
<Title>International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</Title>
<ISOAbbreviation>Int. J. Gynecol. Cancer</ISOAbbreviation>
</Journal>
<ArticleTitle>Patterns of recurrence and role of pelvic radiotherapy in ovarian clear cell adenocarcinoma.</ArticleTitle>
<Pagination><MedlinePgn>1597-602</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1097/IGC.0000000000000270</ELocationID>
<Abstract><AbstractText Label="OBJECTIVE(S)" NlmCategory="OBJECTIVE">The aims of this study were to analyze patterns of recurrence in patients with ovarian clear cell adenocarcinoma (CCA) and to evaluate the role of pelvic radiotherapy (RT).</AbstractText>
<AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">All patients with ovarian CCA treated at a single institution between 1989 and 2012 were identified, and their medical records were reviewed. Eligibility criteria included histologic diagnosis of pure CCA of the ovary, surgical staging for International Federation of Gynecology and Obstetrics stage I-to-IIIC disease, and adjuvant or neoadjuvant chemotherapy. Selected end points were 3-, 5-, and 8-year cumulative incidence of pelvic recurrence (CIPR).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-six patients met eligibility criteria. Most received intravenous carboplatin and paclitaxel for a median of 6 cycles. Six patients (10.7%) received pelvic RT, and 50 (89.3%) did not. Pelvic RT patients had stage I-to-IIC disease. Median follow-up was 39 months (range, 1-69 months). For the group as a whole, 14 patients (25%) had initial disease recurrence involving the pelvis, whereas 6 (10.7%) had first recurrence outside the pelvis. Three-, 5- and 8-year CIPR were 28.2%, 38.5%, and 43.2%, respectively. There was no significant difference in 3-, 5-, or 8-year CIPR between the group of patients receiving RT (20%, 20%, and 20%) and a group of patients with stages I to IIC who did not receive RT (9.9%, 22.4%, and 30.2%), P = 0.22. During RT, patients developed mild grade 1-to-2 side effects. After RT, 1 patient developed lower extremity lymphedema with recurrent cellulitis. One patient who developed small bowel obstruction before RT developed small bowel radiation enteritis and obstruction after RT, ultimately requiring surgical intervention.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These findings suggest that ovarian CCA exhibits a propensity for pelvic recurrence after surgery and chemotherapy. RT, a local treatment that can effectively sterilize microscopic tumor cells, may benefit patients with this disease. Prospective studies with sufficient statistical power are warranted to further evaluate the role of RT.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Macrie</LastName>
<ForeName>Bryan D</ForeName>
<Initials>BD</Initials>
<AffiliationInfo><Affiliation>*Department of Radiation Oncology and †Department of Preventive Medicine, Division of Biostatistics, Northwestern University Feinberg School of Medicine; ‡Robert H. Lurie Comprehensive Cancer Center and §Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Northwestern University Feinberg School of Medicine; ∥Department of Radiation Oncology, Stritch School of Medicine, Loyola University Chicago.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Strauss</LastName>
<ForeName>Jonathan B</ForeName>
<Initials>JB</Initials>
</Author>
<Author ValidYN="Y"><LastName>Helenowski</LastName>
<ForeName>Irene B</ForeName>
<Initials>IB</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rademaker</LastName>
<ForeName>Alfred</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Schink</LastName>
<ForeName>Julian C</ForeName>
<Initials>JC</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lurain</LastName>
<ForeName>John R</ForeName>
<Initials>JR</Initials>
</Author>
<Author ValidYN="Y"><LastName>Small</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
<Suffix>Jr</Suffix>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Int J Gynecol Cancer</MedlineTA>
<NlmUniqueID>9111626</NlmUniqueID>
<ISSNLinking>1048-891X</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList><SupplMeshName Type="Disease" UI="C538090">Ovarian epithelial cancer</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D018262" MajorTopicYN="N">Adenocarcinoma, Clear Cell</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002641" MajorTopicYN="N" Type="Geographic">Chicago</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016889" MajorTopicYN="N">Endometrial Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D060787" MajorTopicYN="N">Neoplasm Grading</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009375" MajorTopicYN="N">Neoplasms, Glandular and Epithelial</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010051" MajorTopicYN="N">Ovarian Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010386" MajorTopicYN="N">Pelvic Neoplasms</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>10</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>10</Month>
<Day>3</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2015</Year>
<Month>7</Month>
<Day>8</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">25275661</ArticleId>
<ArticleId IdType="doi">10.1097/IGC.0000000000000270</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001283 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001283 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:25275661
   |texte=   Patterns of recurrence and role of pelvic radiotherapy in ovarian clear cell adenocarcinoma.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:25275661" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Patterns of recurrence and role of pelvic radiotherapy in ovarian clear cell adenocarcinoma.

Patterns of recurrence and role of pelvic radiotherapy in ovarian clear cell adenocarcinoma.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Curation

No country items

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki